Sysmex Inostics' broad portfolio of molecular assays yields informative data from cfDNA and cfRNA samples to aid in your therapy development
Baltimore, MD /PRNewswire/ - Sysmex Inostics, a global leader in the liquid biopsy revolution, has expanded its offering of CLIA-validated tests to include AML-SEQ™, a focused panel to detect mutations of the three most prevalent genes found in Acute Myeloid Leukemia (...
Bert Vogelstein of Johns Hopkins University in Baltimore, as well as Professor Hartmut Juhl, M.D., CEO of Indivumed GmbH in Hamburg, Germany, the AACR Team Science Award for the translation of research discoveries into the oncology clinic. The principle of liquid biopsy, which established the...
Sysmex Inostics' broad portfolio of molecular assays yields informative data from cfDNA and cfRNA samples to aid in your therapy development
Hamburg, Germany, 2017.09.08 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology is pleased to announce new data fr...
Sysmex Inostics' broad portfolio of molecular assays yields informative data from cfDNA and cfRNA samples to aid in your therapy development